Management of Anhedonia After Epilepsy Surgery

Overview

Journal Epilepsy Behav Rep

Specialty Psychology

Date 2024 Mar 18

PMID 38495401

Authors

Gerardo Maria de Araujo Filho

Antonio L Teixeira

Affiliations

Soon will be listed here.

Abstract

Anhedonia is clinically defined as difficulty or inability to feel pleasure or to be motivated to perform activities that were previously pleasurable. Anhedonia is a core feature of depressive disorders but can be present in other conditions such as substance use and anxiety disorders. Herein we report the case of a 34-year-old female who developed marked anhedonia after left cortico-amygdalohippocampectomy. Despite optimal seizure control, the person struggled with anhedonia and other depressive symptoms. After ruling out medico-neurologic complications, she was prescribed with a selective serotonin reuptake inhibitor and cognitive-behavioral therapy. Anhedonia can be a challenging neuropsychiatric presentation that requires ruling out the effects of antiseizure medications, neurosurgery, and other drugs before prescribing antidepressants.

References

Koch-Stoecker S, Bien C, Schulz R, May T . Psychiatric lifetime diagnoses are associated with a reduced chance of seizure freedom after temporal lobe surgery. Epilepsia. 2017; 58(6):983-993. DOI: 10.1111/epi.13736. View

Kanner A . Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence. Epilepsy Behav. 2016; 61:282-286. DOI: 10.1016/j.yebeh.2016.03.022. View

Castano-Monsalve B . [Antidepressants in epilepsy]. Rev Neurol. 2013; 57(3):117-22. View

Macrodimitris S, Sherman E, Forde S, Tellez-Zenteno J, Metcalfe A, Hernandez-Ronquillo L . Psychiatric outcomes of epilepsy surgery: a systematic review. Epilepsia. 2011; 52(5):880-90. DOI: 10.1111/j.1528-1167.2011.03014.x. View

Guineau M, Ikani N, Rinck M, Collard R, van Eijndhoven P, Tendolkar I . Anhedonia as a transdiagnostic symptom across psychological disorders: a network approach. Psychol Med. 2022; 53(9):3908-3919. PMC: 10317820. DOI: 10.1017/S0033291722000575. View

Schmitz B . Effects of antiepileptic drugs on mood and behavior. Epilepsia. 2006; 47 Suppl 2:28-33. DOI: 10.1111/j.1528-1167.2006.00684.x. View

Chen B, Choi H, Hirsch L, Katz A, Legge A, Buchsbaum R . Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 2017; 76:24-31. DOI: 10.1016/j.yebeh.2017.08.039. View

Kim D, Kim Y, Yang T, Kwon O . Optimal cutoff score of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) for detecting major depressive disorder: A meta-analysis. Epilepsy Behav. 2019; 92:61-70. DOI: 10.1016/j.yebeh.2018.12.006. View

Calabro R, Italiano D, Militi D, Bramanti P . Levetiracetam-associated loss of libido and anhedonia. Epilepsy Behav. 2012; 24(2):283-4. DOI: 10.1016/j.yebeh.2012.03.013. View

10.

Mula M, Brodie M, De Toffol B, Guekht A, Hecimovic H, Kanemoto K . ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy. Epilepsia. 2021; 63(2):316-334. DOI: 10.1111/epi.17140. View

11.

de Araujo Filho G . Can We Anticipate and Prevent the Occurrence of Iatrogenic Psychiatric Events Caused by Anti-seizure Medications and Epilepsy Surgery?. Curr Top Behav Neurosci. 2021; 55:281-305. DOI: 10.1007/7854_2021_228. View

12.

Ketter T, Post R, Theodore W . Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology. 1999; 53(5 Suppl 2):S53-67. View

13.

Mula M, Monaco F . Antiepileptic drugs and psychopathology of epilepsy: an update. Epileptic Disord. 2009; 11(1):1-9. DOI: 10.1684/epd.2009.0238. View

14.

de Araujo Filho G, Mazetto L, Gomes F, Marinho M, Tavares I, Caboclo L . Pre-surgical predictors for psychiatric disorders following epilepsy surgery in patients with refractory temporal lobe epilepsy and mesial temporal sclerosis. Epilepsy Res. 2012; 102(1-2):86-93. DOI: 10.1016/j.eplepsyres.2012.05.005. View

15.

Fiest K, Dykeman J, Patten S, Wiebe S, Kaplan G, Maxwell C . Depression in epilepsy: a systematic review and meta-analysis. Neurology. 2012; 80(6):590-9. PMC: 3589287. DOI: 10.1212/WNL.0b013e31827b1ae0. View

16.

Gilliam F, Black K, Carter J, Freedland K, Sheline Y, Tsai W . A Trial of Sertraline or Cognitive Behavior Therapy for Depression in Epilepsy. Ann Neurol. 2019; 86(4):552-560. PMC: 7012268. DOI: 10.1002/ana.25561. View

17.

Miziak B, Czuczwar S, Pluta R . Comorbid epilepsy and depression-pharmacokinetic and pharmacodynamic drug interactions. Front Pharmacol. 2022; 13:988716. PMC: 9585163. DOI: 10.3389/fphar.2022.988716. View

18.

Teixeira A, Gonzales M, de Souza L, Weisenbach S . Revisiting Apathy in Alzheimer's Disease: From Conceptualization to Therapeutic Approaches. Behav Neurol. 2021; 2021:6319826. PMC: 8356015. DOI: 10.1155/2021/6319826. View

19.

Kanner A, Byrne R, Chicharro A, Wuu J, Frey M . A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology. 2009; 72(9):793-9. DOI: 10.1212/01.wnl.0000343850.85763.9c. View

20.

Maguire M, Weston J, Singh J, Marson A . Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev. 2014; (12):CD010682. PMC: 6769156. DOI: 10.1002/14651858.CD010682.pub2. View